STOCK TITAN

DOCGO INC Stock Price, News & Analysis

DCGO Nasdaq

Welcome to our dedicated page for DOCGO news (Ticker: DCGO), a resource for investors and traders seeking the latest updates and insights on DOCGO stock.

DocGo Inc. (NASDAQ: DCGO) is a provider of technology-enabled mobile health and medical transportation services, and its news flow reflects this focus on out‑of‑facility care. Company press releases highlight developments in its mobile health services, remote patient monitoring, ambulance and medical transport operations, and its 50‑state virtual care network.

Investors following DocGo news can expect regular updates on financial results, including quarterly earnings announcements furnished on Form 8‑K, where the company discusses segment performance for Mobile Health Services and Transportation Services, adjusted gross margin metrics and adjusted EBITDA. These releases often include commentary from management on contract activity, care gap closure volumes, and the evolution of its payer and provider relationships.

DocGo’s news also covers contract wins and program launches, such as care gap closure programs with insurance providers, population health initiatives with public health plans and tribal and state health departments, vaccination programs with counties, and multi‑year ambulance contracts with academic medical systems and municipalities. Announcements describing longitudinal care services and transitions of care programs illustrate how the company uses mobile clinicians and telehealth to engage patients at home.

Another recurring theme in DocGo news is strategic activity and capital allocation. The company has issued releases and filed 8‑Ks regarding the acquisition of virtual care platform SteadyMD, as well as updates on its share repurchase program. In addition, DocGo frequently announces participation in healthcare and growth investor conferences, providing insight into how management presents its strategy to the market.

For anyone tracking DCGO, this news page aggregates these earnings releases, contract announcements, program launches, acquisition updates and conference appearances in one place, offering a consolidated view of the company’s operational and strategic milestones over time.

Rhea-AI Summary

DocGo Inc. (Nasdaq: DCGO) has announced that its subsidiary, Ambulnz, has launched emergency medical and 911 services in Dover, Delaware. Starting July 1, 2024, Ambulnz will provide 24/7 basic life support (BLS) ambulance services from three stations in the Dover Fire District. The company secured a three-year contract through competitive bidding to serve Dover's 38,000 residents.

This expansion builds on DocGo's existing work with the Bayhealth hospital system in Dover since January 2022. The new services are supported by a local management team and over 50 EMS field professionals. Ambulnz has worked to ensure a smooth transition from the previous provider and offered employment to qualified staff members.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

DocGo (Nasdaq: DCGO) has announced a partnership with Spect to enhance eye and vision health services. This collaboration allows DocGo's mobile health clinicians to use Spect's hand-held retinal cameras, providing scalable, cost-effective diabetic retinopathy and other eye disease screenings at patients' homes and workplaces.

This initiative aims to improve patient care and health plan quality ratings by integrating these screenings into DocGo's services. Spect's platform, known for its ease of use and minimal training requirements, can identify various eye diseases, including glaucoma and macular degeneration. The partnership focuses on supporting DocGo's health plan partnership offerings and addressing care gaps through in-home medical visits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.73%
Tags
partnership
-
Rhea-AI Summary

DocGo, a leader in technology-enabled mobile health services, announced five new contracts to enhance its remote patient monitoring (RPM), virtual care management (VCM), and chronic care management (CCM) services. These contracts include partnerships with a national health plan, a Pacific Northwest not-for-profit health system, a hospital clinic in Oklahoma, a cardiovascular institute in Delaware, and an assisted living provider in the Southwest. The contracts are expected to increase patient access to essential healthcare services, helping underserved populations and expanding DocGo's market reach.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
none
Rhea-AI Summary

DocGo, a leading provider of technology-enabled mobile health services, announced its participation in the iAccess Alpha Buyside Best Ideas Summer Conference 2024. Scheduled for June 25 and 26, 2024, the event will feature a presentation by DocGo's CEO, Lee Beinstock, at 2:00 PM Eastern Time on June 25. Additionally, one-on-one meetings with company management will occur on June 26. Organized by iAccess Alpha, the virtual conference will offer company presentations and follow-up meetings between investors and management teams. The event aims to provide investors with valuable insights and networking opportunities. For more details or to schedule a meeting, visit the conference website. The presentation will be webcast live and available for replay on both the conference and DocGo's investor relations websites.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.6%
Tags
conferences
-
News
Rhea-AI Summary

DocGo (Nasdaq: DCGO), a prominent provider of mobile health services, announced the creation of a Medical Advisory Board (MAB) to support its executive team. The MAB will aid DocGo in enhancing its virtual, in-person, and mobile healthcare services in the US and UK. The board includes distinguished professionals such as Dr. Ben Bobrow, Dr. Jagmeet Singh, Dr. Andy Jagoda, Dr. Clive Kevan Fields, Dr. Ries Robinson, Dr. Jesse Roach, and Dr. James Powell. Their collective expertise will help drive innovation, improve healthcare access, and elevate patient care. The MAB aims to meet regularly and may expand to include more specialties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.3%
Tags
management
-
Rhea-AI Summary

DocGo (Nasdaq: DCGO), a prominent provider of technology-enabled mobile health services, has been recognized by U.S. News & World Report as one of the 2024-2025 Best Companies to Work For. This accolade highlights DocGo's commitment to meeting employee needs and fostering a positive work environment. Factors considered include quality of pay and benefits, work-life balance, stability, and career opportunities. DocGo's CEO, Lee Bienstock, emphasized that the company's success is driven by its dedicated team, reinforcing their mission to provide high-quality healthcare. The rankings included 549 companies and were based on data such as employee sentiment and reviews.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.94%
Tags
none
Rhea-AI Summary

DocGo, a leader in technology-enabled mobile health services, announced its upcoming participation at the Stifel Cross Sector Insight Conference.

CEO Lee Bienstock will present on June 5 at 1:15 PM Eastern Time.

A webcast of the event will be available on the investor relations section of DocGo's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
none
-
Rhea-AI Summary

DocGo Inc. (Nasdaq: DCGO) reported strong first-quarter 2024 results with total revenue of $192.1 million, a 70% increase from the previous year. The company achieved a net income of $10.6 million, a significant improvement from a net loss in the same period last year. Adjusted EBITDA reached $24.1 million, up 330% year-over-year. Despite a revision in revenue guidance due to the wind-down of migrant services, DocGo remains optimistic about its base business growth and expects an adjusted EBITDA margin of over 10% in 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.14%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.99%
Tags
none

FAQ

What is the current stock price of DOCGO (DCGO)?

The current stock price of DOCGO (DCGO) is $0.5386 as of April 14, 2026.

What is the market cap of DOCGO (DCGO)?

The market cap of DOCGO (DCGO) is approximately 51.3M.